Resultado de búsqueda
25 de abr. de 2023 · Anne Wojcicki is the co-founder and CEO of 23andme. Jordan Vonderhaar—Bloomberg/Getty Images Sequencing the human genome for the first time was an incredible feat.
Anne Wojcicki, CEO of 23andMe By the numbers. 2006. The year we set out to make DNA more accessible and meaningful for all. 12M+ The number of DNA kits we’ve sold in that time. 55+ The number of health reports that meet FDA requirements. Discover more about 23andMe. Blog.
Susan Diane Wojcicki (/ w ʊ ˈ tʃ ɪ t s k i / wuutch-ITS-kee; born July 5, 1968) is an American business executive who was the chief executive officer (CEO) of YouTube from 2014 to 2023. Her net worth was estimated at $765 million in 2022. Wojcicki has worked in the technology industry for over twenty years. She became involved in the creation of Google in 1998 when she rented out her ...
23 de may. de 2022 · "By having a large amount of data, we are starting to understand, what does the human genome mean?" In this View From The Top, Alexandra Eitel, MBA '22 sits ...
Anne Wojcicki CEO and Co-Founder. Anne co-founded 23andMe in 2006, three years after the first human genome was sequenced. Her goal was audacious: to help people access, understand, and benefit from the human genome and fundamentally change healthcare in the process. Prior to ...
29 de abr. de 2022 · Anne Wojcicki: Early Life and Education. Anne Wojcicki began her life on July 28, 1973 in Palo Alto, California. She isn’t the only one in her family to amass wild success. Her two older sisters, Susan and Janet, have done some incredible things with their careers. Susan Wojcicki acts as the CEO of YouTube, and Janet Wojcicki works as an ...
Anne Wojcicki (born July 28, 1973, San Mateo county, California) is an American entrepreneur and cofounder and chief executive officer of the personal genetics company 23andMe.. Wojcicki received a B.S. degree (1996) in biology from Yale University.She later worked as a researcher and as an investment analyst. In 2006, while pursuing her interest in the potential to influence health care ...
